Evidence map›Paper›PMID 32408786›Full record

ArticleRenal failure2020

DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose.

Ying-Li Zhang, Jie-Min Wang, Hong Yin, Shou-Bao Wang, Cai-Ling He, Jing Liu

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ying-Li ZhangDepartment of Endocrinology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, P. R. China.
Jie-Min WangDepartment of Endocrinology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, P. R. China.
Hong YinDepartment of Endocrinology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, P. R. China.
Shou-Bao WangDepartment of Endocrinology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, P. R. China.
Cai-Ling HeDepartment of Endocrinology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, P. R. China.
Jing LiuDepartment of Endocrinology, The People's Hospital of Gansu Province, Lanzhou, Gansu, P. R. China.
First Hospital of Lanzhou University · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epithelial-Mesenchymal TransitionApoptosisCell LineCell SurvivalEye ProteinsGlucoseHumansInflammationKidneyMicroRNAsTranscription FactorsDACH1 protein, humanEye ProteinsGlucoseMicroRNAsMIRN218 microRNA, humanTranscription FactorsDACH1Diabetic kidney diseaseinflammationmicroRNA-218proliferation

Identifiers

PMID32408786
PMCPMC7269034
OpenAlexW3024050965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.